Our aim is to ensure our research can be constructively applied by the many stakeholders working in access to medicine. We regularly speak about our research at conferences, workshops and roundtables in order to share our findings and advance the discussion between health experts, industry leaders and governments around the globe.
In light of the current COVID-19 epidemic, we are keeping our speaking commitments under review.
Date: 22 November 2018
Date: 22 January 2018
View our detailed overview of each company’s performance in the Index, including breakdowns of their product portfolios and R&D pipelines.